Publications by authors named "Raphael Scherbaum"

Claim this Profile
U
User groups of inpatient multidisciplinary therapies for Parkinson's disease in Germany: a bicenter prospective observational study.
Vera Tschentscher, Judith Oppermann, Julius Welzel, Johanna Geritz, Ralf Gold, Raphael Scherbaum

Neurol Res Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's Disease Multidisciplinary Complex Therapy (PD-MCT): appreciation of its current function for the treatment of people with Parkinson's disease in Germany and the needs of future development.
Raphael Scherbaum, Matthias Höllerhage, Stephan Klebe, Peter Riederer, Thomas Müller

J Neural Transm (Vienna)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing decision-making skills with the Script Concordance Test (SCT) in clinical neurology and emergency medicine.
Helena-Fee Gudorf, Maximilian Heidrich, Kristoph Rauchstädt, Raphael Scherbaum, Lars Tönges

BMC Med Educ· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-fiber neuropathy in Parkinson's disease: a narrative review.
Eun Hae Kwon, Julia Steininger, Raphael Scherbaum, Ralf Gold, Kalliopi Pitarokoili

Neurol Res Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal evaluation of polyneuropathy in Parkinson's disease.
Eun Hae Kwon, Antonia Bieber, Paula Schülken, Katharina Müller, Eva Kühn, Raphael Scherbaum

J Neurol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and device-based predictors of improved experience of activities of daily living after a multidisciplinary inpatient treatment for people with Parkinson's disease: a cohort study.
Judith Oppermann, Vera Tschentscher, Julius Welzel, Johanna Geritz, Clint Hansen, Raphael Scherbaum

Ther Adv Neurol Disord· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Multidisciplinary Complex Treatment of Parkinson's disease : Cornerstone of an individualized treatment].
Raphael Scherbaum, Lars Tönges

Nervenarzt· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-driven subtyping of Parkinson's disease: comparison of current methodologies and application to the Bochum PNS cohort.
Qiang Chen, Raphael Scherbaum, Ralf Gold, Kalliopi Pitarokoili, Axel Mosig

J Neural Transm (Vienna)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study.
Raphael Scherbaum, Andreas Moewius, Judith Oppermann, Johanna Geritz, Clint Hansen

J Neurol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 outcomes in hospitalized Parkinson's disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany.
Raphael Scherbaum, Dirk Bartig, Daniel Richter, Eun Hae Kwon, Siegfried Muhlack

Neurol Res Pract· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany.
Raphael Scherbaum, Eun-Hae Kwon, Daniel Richter, Dirk Bartig, Ralf Gold

Brain Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study.
Rachel Rohmann, Eva Kühn, Raphael Scherbaum, Lovis Hilker, Saskia Kools

Brain Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany.
Raphael Scherbaum, Eun Hae Kwon, Daniel Richter, Dirk Bartig, Ralf Gold

Mov Disord· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany.
Daniel Richter, Raphael Scherbaum, Dirk Bartig, Ralf Gold, Christos Krogias

Parkinsonism Relat Disord· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement.
Elke Hartelt, Raphael Scherbaum, Manuel Kinkel, Ralf Gold, Siegfried Muhlack

J Clin Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.
Raphael Scherbaum, Elke Hartelt, Manuel Kinkel, Ralf Gold, Siegfried Muhlack

J Neurol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers.
Daniel Richter, Dirk Bartig, Siegfried Muhlack, Elke Hartelt, Raphael Scherbaum

Cells· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis